United Therapeutics Corp - ESG Rating & Company Profile powered by AI
This ESG rating includes 17 United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. This assessment of United Therapeutics Corp uses data points from across the web as well as from available disclosures by United Therapeutics Corp. Jump to the bottom of the page for potential risks for United Therapeutics Corp based on industry, location and marketcap.
United Therapeutics Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 5.3, social score of 4.6 and governance score of 6.7.
5.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 602 | SkinBioTherapeutics PLC | 5.6 | High |
| 602 | XOMA Corp | 5.6 | High |
| 627 | United Therapeutics Corp | 5.5 | High |
| 627 | Advanced Medical Solutions Group PLC | 5.5 | High |
| 627 | Achieve Life Sciences Inc | 5.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does United Therapeutics Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes United Therapeutics Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes United Therapeutics Corp report the average age of the workforce?
Sign up for free to unlockDoes United Therapeutics Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes United Therapeutics Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes United Therapeutics Corp disclose cybersecurity risks?
Sign up for free to unlockDoes United Therapeutics Corp offer flexible work?
Sign up for free to unlockDoes United Therapeutics Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes United Therapeutics Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes United Therapeutics Corp conduct supply chain audits?
Sign up for free to unlockDoes United Therapeutics Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes United Therapeutics Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes United Therapeutics Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes United Therapeutics Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes United Therapeutics Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes United Therapeutics Corp disclose water use targets?
Sign up for free to unlockDoes United Therapeutics Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid United Therapeutics Corp have a product recall in the last two years?
Sign up for free to unlockDoes United Therapeutics Corp disclose incidents of discrimination?
Sign up for free to unlockDoes United Therapeutics Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas United Therapeutics Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes United Therapeutics Corp disclose parental leave metrics?
Sign up for free to unlockDoes United Therapeutics Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes United Therapeutics Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes United Therapeutics Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes United Therapeutics Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes United Therapeutics Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes United Therapeutics Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs United Therapeutics Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes United Therapeutics Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes United Therapeutics Corp disclose its waste policy?
Sign up for free to unlockDoes United Therapeutics Corp report according to TCFD requirements?
Sign up for free to unlockDoes United Therapeutics Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes United Therapeutics Corp disclose energy use targets?
Sign up for free to unlockDoes United Therapeutics Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes United Therapeutics Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for United Therapeutics Corp
These potential risks are based on the size, segment and geographies of the company.
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing Tyvaso DPI, a dry powder inhalation form of Tyvaso; Remunity Pump, a small, lightweight, durable pump and separate controller; RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Tyvaso PERFECT and TETON studies, which are the studies of Tyvaso in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.